Login Get Started
Browse
Shares
Healthcare
Biotechnology & Medical Research
Cellular Biomedicine Inc
Cellular Biomedicine Inc logo

CBMG - Cellular Biomedicine Inc Share News

$18.24 0.2  1.3%

Last Trade - 22/01/21

Sector
Healthcare
RiskRating
Adventurous
Size
Small Cap
Style
Momentum Trap
Market Cap £259.6m
Enterprise Value £275.6m
Revenue £236k
Position in Universe 3725th / 6630
Quality
Value
Momentum
StockRank™
StockReport™
Tools
Compare with... Run through checklist
Accounts
Balance sheet Income statement Cashflow statement Dividend summary
Charts News Discussions CBMG Dividends
All News
All News Reuters News Company Announcements
BRIEF-Cellular Biomedicine Group, Unit, Novartis AG Entered Toll Manufacturing & Supply Agreement On Dec 21- Sec Filing
28th Dec '18 News
Cellular Biomedicine Group Appoints CAR-T Pioneer Dr. Stephan A. Grupp as Member of Scientific Advisory Board
18th Dec '18 News
BRIEF-Cellular Biomedicine Says China FDA Accepted IND Application For Off-The-Shelf Therapy Allojoin
7th Nov '18 News
BRIEF-Cellular Biomedicine Q3 Non-GAAP Loss Per Share $0.56
6th Nov '18 News
Cellular Biomedicine Group Reports Third Quarter Financial Results and Recent Business Highlights
6th Nov '18 News
Cellular Biomedicine Group to Provide Company Cancer Immunotherapy Pipeline Update and Facility Tour for Attendees of the Advanced Cell Therapy Summit in Shanghai
25th Oct '18 News
BRIEF-Cellular Biomedicine Group Says Commenced Share Repurchase Program
10th Oct '18 News
BUZZ-U.S. STOCKS ON THE MOVE-Tesla, J.C. Penney, Intel, Michael Kors, GM, Alcoa
3rd Oct '18 News
BUZZ-U.S. STOCKS ON THE MOVE-Tesla, AMD, Baker Hughes, PulteGroup, J. C. Penney
3rd Oct '18 News
BUZZ-Cellular Biomedicine: Gains on license pact with NCI
3rd Oct '18 News
BRIEF-Cellular Biomedicine Gets NCI Patent License For Technology To Treat Solid Tumors
3rd Oct '18 News
Cellular Biomedicine Group Obtained NCI Patent License for Next Generation Neoantigen-Reactive Tumor Infiltrating Lymphocyte (TIL) Technology to Treat  Solid Tumors
3rd Oct '18 News
UPDATE 1-Novartis strikes deal with Chinese firm to make Kymriah
27th Sep '18 News
Novartis strikes deal with Chinese firm to make Kymriah
27th Sep '18 News
BUZZ-U.S. STOCKS ON THE MOVE-Aetna, Amazon, Geron, Apple
27th Sep '18 News
BUZZ-Cellular Biomedicine: Jumps on deal for Novartis' Kymriah in China
27th Sep '18 News
NASDAQ RESUMED
27th Sep '18 News
BRIEF-Cellular Biomedicine Group Enters Into Strategic Licensing And Collaboration Agreement With A Global Leader In Car-T Cell Therapy For Patients In China
27th Sep '18 News
NASDAQ TRADE HALT HALT NEWS PENDING
27th Sep '18 News
Cellular Biomedicine Group to Present at the Cantor Fitzgerald 2018 Global Healthcare Conference
24th Sep '18 News
© Stockopedia 2021, Refinitiv, Share Data Services.
Youtube Instagram RSS
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.